Lynda Charters

Emerging anti-VEGF agents offer enhanced durability and anatomic outcomes in retinal disease.

Cases show improved clarity, astigmatism masking, and versatility in complex eyes.

Earlier use of SLT, sustained-release drug delivery, and MIGS is reframing glaucoma care.

Roundtable discussion explores surgical and sustained-release options.

A study reveals that systemic chemotherapy significantly reduces mortality in retinoblastoma, while targeted treatments lower enucleation rates.

New research reveals subretinal drusenoid deposits in Black and Hispanic AMD patients may signal higher vascular disease risk

AMD treatment may become unrecognizable as gene therapies evolve.

While the injuries associated with other similar sports, such as tennis, badminton, and racquetball have been investigated in many studies, no epidemiologic studies have specifically focused on the incidence of ocular injuries that occur in pickleball

In this murine model of glaucoma, SPG302 was administered daily to 3-month-old mice for 8 weeks.

As ophthalmic technologies move at supersonic speed, AI and gene therapy take center stage.

Explore groundbreaking advancements in eye care from the 2000s, including LASIK innovations, anti-VEGF treatments, and enhanced imaging technologies.

Explore the groundbreaking advancements in ophthalmic technology from the 1980s and 1990s, including excimer lasers, LASIK, and innovative imaging techniques.

From lasers to lenses, the 1970s redefined vision care through breakthroughs in surgery, imaging, and therapeutics.

A recent study uncovers a novel biomarker for retinal vascular diseases, highlighting the significance of intermittent capillary perfusion in monitoring treatment efficacy.

Maximizing treatment based on GA location, lesion progression, and morphologic retinal changes.

Join the American Academy of Ophthalmology's annual meeting for cutting-edge insights, networking, and engaging events from October 17-20 in Orlando.

The procedure showed positive effects on the electroretinography (ERG) (b-wave, oscillatory potentials), optomotor response, and contrast sensitivity in actively treated eyes compared with controls.

A study reveals diverse ocular symptoms in Sjögren’s disease, linking eye features to oral and pain manifestations for personalized treatment strategies.

A recent study reveals that most UK patients with geographic atrophy find intravitreal complement inhibitors acceptable, emphasizing the importance of perceived visual benefits.

The trial results show promising for the evaluated gene therapy for the treatments of LCA, showing significant vision improvements in pediatric patients.

A study reveals atropine induces less myopic refraction than cyclopentolate in preschoolers, impacting premyopia diagnosis and intervention strategies.

Considering rapid increases in myopia, authors conducted a longitudinal cohort study of twins and their parents with the goal of exploring the intergenerational changes in the myopia epidemic in China.

A study reveals that repetitive head impacts in college football players do not significantly affect smooth pursuit eye movement velocity during a season.

Canadian researchers reveal increased complications in cataract surgeries during the COVID-19 pandemic, highlighting risks and factors affecting outcomes.

Potential loss to follow-up is a critical issue for these patients with glaucoma.

Mark your calendars: On September 26 and 27, 2025, the Ophthalmology Times and Optometry Times EyeCon 2025 conference will convene at the Margaritaville Hollywood Beach Resort in Hollywood, Florida.